Literature DB >> 910402

Treatment of intractable ascites by continuous reinfusion of the sterilized, cell-free and concentrated ascitic fluid.

N Inoue, Z Yamazaki, T Oda, M Sugiura, T Wada.   

Abstract

The new method for continuous reinfusion of sterilized, cell-free and concentrated ascitic fluid is described, and utilized in 72 patients with intractable ascites in both malignancy as well as liver cirrhosis and is described with satisfactory results. The management by repeated ascites reinfusion of patients with benign massive ascites has been possible. This method is capable of being applied to patients with malignant ascites. Symptomatic relief and prolonged survival time is anticipated. The method described in this study is simple and free of adverse effects.

Entities:  

Mesh:

Year:  1977        PMID: 910402

Source DB:  PubMed          Journal:  Trans Am Soc Artif Intern Organs        ISSN: 0066-0078


  11 in total

1.  Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites associated with cancerous peritonitis: its effect and future perspectives.

Authors:  Keisuke Matsusaki; Keiichiro Ohta; Akitaka Yoshizawa; Yasuaki Gyoda
Journal:  Int J Clin Oncol       Date:  2011-02-24       Impact factor: 3.402

2.  Abstracts of selected papers presented at the 29th annual meeting of the Japanese Society of Gastroenterology. Kofu, Japan, November 5-7, 1987.

Authors: 
Journal:  Gastroenterol Jpn       Date:  1988-10

3.  Plasma-separation in myasthenia gravis: a new method of rapid plasma exchange.

Authors:  W Samtleben; U A Besinger; K V Toyka; A Fateh-Moghadam; G Brehm; H J Gurland
Journal:  Klin Wochenschr       Date:  1980-01-02

4.  Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.

Authors:  Rumi Hanada; Naosuke Yokomichi; Chihiro Kato; Kazumi Miki; Sachiko Oyama; Tatsuya Morita; Ryoko Kawahara
Journal:  Support Care Cancer       Date:  2017-11-22       Impact factor: 3.603

5.  [Plasma separation with membranes--examinations in man (author's transl)].

Authors:  H G Sieberth; W Glöckner; H H Hirsch; H Borberg; G Dotzauer; P Mathieu
Journal:  Klin Wochenschr       Date:  1980-06-02

6.  Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancer.

Authors:  Osamu Maeda; Takafumi Ando; Kazuhiro Ishiguro; Osamu Watanabe; Ryoji Miyahara; Masanao Nakamura; Kohei Funasaka; Furukawa Kazuhiro; Yuichi Ando; Hidemi Goto
Journal:  Mol Clin Oncol       Date:  2014-07-04

7.  Verification of serum albumin elevating effect of cell-free and concentrated ascites reinfusion therapy for ascites patients: a retrospective controlled cohort study.

Authors:  Yosuke Yamada; Keita Inui; Yuuta Hara; Kazuaki Fuji; Kosuke Sonoda; Koji Hashimoto; Yuji Kamijo
Journal:  Sci Rep       Date:  2019-07-15       Impact factor: 4.379

8.  Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites.

Authors:  Naosuke Yokomichi; Kengo Imai; Masaki Sakamoto; Masashi Horiki; Toshihiro Yamauchi; Satoru Miwa; Satoshi Inoue; Yu Uneno; Hidekazu Suzuki; Toru Wada; Yuri Ichikawa; Tatsuya Morita
Journal:  BMC Cancer       Date:  2022-02-28       Impact factor: 4.430

Review 9.  Management of refractory cirrhotic ascites: challenges and solutions.

Authors:  Hiroshi Fukui; Hideto Kawaratani; Kosuke Kaji; Hiroaki Takaya; Hitoshi Yoshiji
Journal:  Hepat Med       Date:  2018-07-03

10.  Development of a novel automatic ascites filtration and concentration equipment with multi-ring-type roller pump units for cell-free and concentrated ascites reinfusion therapy.

Authors:  Toshiya Okahisa; Masahiro Sogabe; Tadahiko Nakagawa; Kumiko Tanaka; Tetsu Tomonari; Tatsuya Taniguchi; Akira Takahashi; Yohsuke Kinouchi; Junji Nishioka; Naoki Igata; Hiroaki Yanagawa; Takatoshi Komatsu; Yoshiaki Ohnishi; Masashi Fukuhara; Masashi Ishikawa; Hiroshi Shibata; Hirohiko Shinomiya; Masahiko Nakasono; Fumiko Kishi; Keiko Komai; Yayoi Tatsuki; Toru Murashima; Yoshihiro Deguchi; Hiroshi Aramaki; Hideyuki Fukumitsu; Tetsuji Takayama
Journal:  Artif Organs       Date:  2020-06-02       Impact factor: 3.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.